Literature DB >> 24012923

Impact of obesity on outcomes of hysterectomy.

Megan D McMahon1, Dana Marie Scott1, Erin Saks1, Amanda Tower1, Christina A Raker1, Kristen A Matteson2.   

Abstract

STUDY
OBJECTIVES: To evaluate the impact of obesity on complications of hysterectomy. STUDY
DESIGN: Retrospective cohort study (Canadian Task Force II-2).
SETTING: The Department of Obstetrics and Gynecology, Women and Infants Hospital of Rhode Island, Providence, RI. PATIENTS: Patients who had a hysterectomy at WIH between July 2006 and January 2009.
INTERVENTIONS: Hysterectomy by any mode.
MEASUREMENTS AND MAIN RESULTS: We collected data from medical records of all laparoscopic hysterectomies during the time period and collected data from a random subset of abdominal and vaginal hysterectomies. The independent variable, body mass index, was grouped according to World Health Organization guidelines. A composite of surgical complications was generated. Multivariable logistic regression was used to estimate adjusted odds ratios (ORs) and 95% confidence intervals (CIs). We collected data from 907 hysterectomies, and 29.9% (n = 267) of the population was obese. Eighteen percent of patients (n = 154) had at least 1 complication. Compared to non-obese women, obese women were at increased odds of having any complication (OR 1.62, 95% CI 1.12-2-34). Performing subgroup analyses by mode of hysterectomy and controlling for confounding factors, we were unable to detect differences odds of complications between obese and non-obese women who underwent either an abdominal, vaginal, or laparoscopic hysterectomy.
CONCLUSION: In our study, we found that among women who had a hysterectomy, obese women had a higher rate of complications than nonobese women.
Copyright © 2014 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complications; Hysterectomy; Obesity

Mesh:

Year:  2013        PMID: 24012923      PMCID: PMC4285148          DOI: 10.1016/j.jmig.2013.08.707

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  18 in total

1.  ACOG Committee Opinion No. 444: choosing the route of hysterectomy for benign disease.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-11       Impact factor: 7.661

2.  The Clavien-Dindo classification of surgical complications: five-year experience.

Authors:  Pierre A Clavien; Jeffrey Barkun; Michelle L de Oliveira; Jean Nicolas Vauthey; Daniel Dindo; Richard D Schulick; Eduardo de Santibañes; Juan Pekolj; Ksenija Slankamenac; Claudio Bassi; Rolf Graf; René Vonlanthen; Robert Padbury; John L Cameron; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

3.  Total laparoscopic hysterectomy for uterine pathology: impact of body mass index on outcomes.

Authors:  Katherine A O'Hanlan; Suzanne L Dibble; Deidre T Fisher
Journal:  Gynecol Oncol       Date:  2006-07-10       Impact factor: 5.482

4.  The effect of obesity on total abdominal hysterectomy.

Authors:  Oz Harmanli; Vani Dandolu; Jeff Lidicker; Reyhan Ayaz; Uma R Panganamamula; Ebru F Isik
Journal:  J Womens Health (Larchmt)       Date:  2010-10       Impact factor: 2.681

5.  Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals.

Authors:  E David-Montefiore; R Rouzier; C Chapron; E Daraï
Journal:  Hum Reprod       Date:  2006-09-01       Impact factor: 6.918

6.  What's the impact of the obesity on the safety of laparoscopic hysterectomy techniques?

Authors:  William Kondo; Nicolas Bourdel; Francesca Marengo; Revaz Botchorishvili; Jean Luc Pouly; Kris Jardon; Benoit Rabischong; Gérard Mage; Michel Canis
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2012-10-15       Impact factor: 1.878

7.  Total laparoscopic hysterectomy in obese versus nonobese patients.

Authors:  Eric M Heinberg; Benjamin L Crawford; Sherry H Weitzen; David J Bonilla
Journal:  Obstet Gynecol       Date:  2004-04       Impact factor: 7.661

8.  Hysterectomy rates in the United States, 2003.

Authors:  Jennifer M Wu; Mary Ellen Wechter; Elizabeth J Geller; Thao V Nguyen; Anthony G Visco
Journal:  Obstet Gynecol       Date:  2007-11       Impact factor: 7.661

Review 9.  Surgical approach to hysterectomy for benign gynaecological disease.

Authors:  Theodoor E Nieboer; Neil Johnson; Anne Lethaby; Emma Tavender; Elizabeth Curr; Ray Garry; Sabine van Voorst; Ben Willem J Mol; Kirsten B Kluivers
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

10.  Total laparoscopic hysterectomy for benign uterine pathologies: obesity does not increase the risk of complications.

Authors:  Nicolas Chopin; Jean Marie Malaret; Marie-Christine Lafay-Pillet; Adolphe Fotso; Hervé Foulot; Charles Chapron
Journal:  Hum Reprod       Date:  2009-10-03       Impact factor: 6.918

View more
  4 in total

1.  Safely Increase the Minimally Invasive Hysterectomy Rate: A Novel Three-Tiered Preoperative Categorization System Can Predict the Difficulty for Benign Disease.

Authors:  Esteban Andryjowicz; Teresa B Wray; V Reinaldo Ruiz; James Rudolf; Sara Noroozkhani; Sandra Crowder; Jeff M Slezak
Journal:  Perm J       Date:  2015-07-24

Review 2.  Association between body mass index and urinary tract infection: a systematic review and meta-analysis of observational cohort studies.

Authors:  Habeeb Alhabeeb; Saeed Baradwan; Hamed Kord-Varkaneh; Shing Cheng Tan; Teck Yew Low; Osama Alomar; Hany Salem; Ismail Abdulrahman Al-Badawi; Ahmed Abu-Zaid
Journal:  Eat Weight Disord       Date:  2021-01-09       Impact factor: 4.652

Review 3.  Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?

Authors:  Molly Dore; Sara Filoche; Kirsty Danielson; Claire Henry
Journal:  Gynecol Oncol Rep       Date:  2021-02-19

4.  Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells.

Authors:  Molly Dore; Sara Filoche; Kirsty Danielson; Claire Henry
Journal:  Cancer Manag Res       Date:  2021-10-14       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.